Mesothelioma Statistics

Fact Checked

Mesothelioma statistics show about 3,000 new cases of the asbestos-related disease are diagnosed each year in the United States. Pleural mesothelioma accounts for 75% of cases, and the average age at diagnosis is between 65 and 72. Statistics for mesothelioma also show life expectancy is 12-22 months.

Free 2019 Mesothelioma Guide

Key Facts About Mesothelioma

Knowing key mesothelioma statistics can help you better understand this rare disease, make more educated decisions about your health and help spread awareness.

  • Mesothelioma is caused by exposure to asbestos.
  • It accounts for less than 0.3% of all cancer diagnoses in the country.
  • There are four types of mesothelioma: Pleural, peritoneal, pericardial and testicular. Pleural is the most common type, representing about 75% of all mesothelioma cases.
  • Out of all people with heavy, prolonged exposure to asbestos, 2% to 10% develop pleural mesothelioma.
  • Symptoms of mesothelioma usually do not show until 20-50 years after asbestos exposure, which is when tumors have grown and spread.
  • The average life expectancy for mesothelioma patients is 12 to 22 months.

Who Gets Mesothelioma?

The typical mesothelioma patient is a man older than 65 with a blue-collar or military background. However, anyone with a history of asbestos exposure is at risk.

Occupations with Greatest Risk of Asbestos Exposure

  • Construction
  • Firefighting
  • Manufacturing
  • Chemical refining
  • Power generation
  • Shipbuilding
  • Military service

Demographic Factors in Mesothelioma Incidence

Mesothelioma incidence describes the risk of getting mesothelioma cancer. Because men are exposed to asbestos more often, they are 4.6 times more likely to be diagnosed with mesothelioma. Of all diagnosed patients, more than 90% are white. Hispanics are diagnosed more frequently than blacks or Asians.

Mesothelioma Incidence by Gender

Bar graph displaying mesothelioma incidence by gender. SEER Cancer Statistics Review 2012-2015

Mesothelioma Incidence by Race/Ethnicity

Bar graph displaying mesothelioma incidence by race/ethnicity. CDC National Program of Cancer Registries and SEER, 2003-2008
Quick Fact:

The risk for developing mesothelioma is 10 times higher for people older than 60 compared to people younger than 40.

Latency Period of Mesothelioma

The gap between the first exposure to asbestos and the appearance of symptoms is called the latency period. Mesothelioma symptoms typically appear 20 to 50 years after exposure to asbestos.

Timeline displaying mesothelioma latency period for men and women following asbestos exposure.
Mesothelioma latency period timeline

Average Latency Periods by Mesothelioma Type

  • Pleural Mesothelioma: 30 to 60 years
  • Peritoneal Mesothelioma: 20 to 40 years

Mortality & Survival Rates of Mesothelioma

Mesothelioma is a complex disease, and few doctors have experience diagnosing and treating it. Mesothelioma specialists offer patients the greatest hope.

Death Toll of Mesothelioma

  • From 1999 to 2015, a total of 45,221 Americans died from mesothelioma.
  • Nearly 80% of those deaths occurred among men.
  • About 37% of deaths were people ages 75 to 84.

Mesothelioma Death Rate by State, 1999-2015

Map displaying mesothelioma death rates by state.
Mesothelioma death rates are highest in the Northeast, Northwest and Midwest.
CDC, 2017

Pleural Mesothelioma Survival Rates by Stage at Diagnosis

Doctors sort mesothelioma cases into stages to describe how far the cancer has spread. The mesothelioma stage at diagnosis affects the patient’s treatment options and prognosis.

Median Survival Time by Mesothelioma Stage
Mesothelioma Stage Median Survival Time
Stage 1 22.2 months
Stage 2 20 months
Stage 3 17.9 months
Stage 4 14.9 months

Source: Journal of Thoracic Oncology, 2016

The National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program tracks 5-year relative survival rates for pleural mesothelioma by three groups: Localized, regional and distant stages.

5-Year Survival Rates for Pleural Mesothelioma
SEER Stage 5-Year Survival Rate
All SEER Stages 9%
Localized 18%
Regional 11%
Distant 7%

Source: SEER; 2008 and 2014

Demographic Factors in Mesothelioma Survival Rates

Research shows survival among women diagnosed with pleural mesothelioma is three times higher than survival for men. One 2014 study reported 13.4% of women survive for five years after treatment, compared to only 4.5% of men.

The one-year survival rate is about the same for all races. From three years on, survival is slightly worse for whites.

5-Year Mesothelioma Survival by Race

Bar graph displaying 5-Year mesothelioma survival by race National Cancer Institute, 2018

Overall, younger mesothelioma patients have a significantly higher survival rate than older patients. More than 50% of patients diagnosed before the age of 50 survive one year, while less than 33% of those 75 or older survive the same length of time.

Get Free Help Finding a Mesothelioma Specialist

Connect to a top specialist who understands your diagnosis and can recommend treatment options.

Find a Doctor Near You

Where Does Mesothelioma Occur?

Most mesothelioma cases occur in the pleura, the tissue lining surrounding the lungs. About 20% of cases appear in the peritoneum, which is the lining of the abdomen.

In 1% of cases, the cancer forms in the pericardium, also known as the lining of the heart. Less than 1% of cases are in the tunica vaginalis, which is the lining of the testes.

Diagram showing the types of mesothelioma as a percentage of all cases
Asbestos usually enters the body through the lungs, which is why pleural mesothelioma is the most common type.

Mesothelioma Survival Rates by Site

Medical advances have made peritoneal mesothelioma easier to treat than pleural mesothelioma. A 2015 study from Translational Oncology reveals a large difference in survival rates.

Line graph displaying survival rates for Pleural and Peritoneal Mesothelioma since the year of diagnosis.
The study data show that most patients survived a year after diagnosis, but longer-term survival rates were higher for peritoneal patients.
Source: Translational Oncology, 2015

Symptoms by Site

Mesothelioma symptoms vary depending on where the cancer forms. Mesothelioma can be challenging to diagnose because early-stage symptoms are usually mild or nonexistent.

Symptom Pleural Peritoneal Pericardial
Abdominal Distention
Abdominal Swelling or Tenderness
Anemia
Loss of Appetite
Bowel Obstruction
Chest Pains
Chills
Cough
Couging up Blood
Difficulty Breathing
Fatigue
Feeling of Fullness
Fever
Fluid Buildup
Lumps Under Abdominal Skin
Lumps Under Skin of the Chest
Heart Failure
Heart Palpitations
Hernias
Irregular Heartbeat
Murmurs
Night Sweats
Pain
Pressure on the Heart
Reduced Chest Expansion
Shortness of Breath
Vomiting
Weight Loss
Wheezing

Benefits from Cancer Treatment

Mesothelioma treatment may involve surgery, chemotherapy and radiation therapy. Patients can also enroll in clinical trials to try experimental treatments such as immunotherapy.

Key Stats About Mesothelioma Treatment

  • More than 80% of patients receive chemotherapy, the most common treatment for mesothelioma.
  • A 2016 study compiling SEER data showed chemotherapy tripled the survival rate of patients diagnosed with pleural or peritoneal mesothelioma.
  • Less than 20% of pleural mesothelioma patients qualify for aggressive tumor-removing surgery.
  • Half of peritoneal mesothelioma patients who receive HIPEC surgery live longer than five years.

Research has shown improved survival with multimodal therapy, an approach that combines two or more treatments.

A 2018 study presented at the eighth annual European Lung Cancer Congress showed a combination of surgery, chemotherapy and radiation produced an impressive one-year survival rate of 79.6% for pleural mesothelioma patients.

Combining surgery with chemotherapy is also effective for peritoneal mesothelioma. A 2018 International Journal of Hyperthermia study showed median disease-free survival was almost five years for peritoneal patients receiving HIPEC surgery, which combines cytoreductive surgery with heated chemotherapy. The median overall survival for patients in the study was more than eight years.

Only about 20% of pleural mesothelioma patients are eligible for aggressive tumor-removing surgery. For the rest, doctors are testing experimental drug regimens, including immunotherapy drugs already used in lung cancer treatment.

Immunotherapy Drugs Being Tested for Mesothelioma

  • Pembrolizumab (Keytruda)
  • Nivolumab (Opdivo)
  • Ipilimumab (Yervoy)
  • CRS-207
  • WT1 Vaccine

Human studies, called clinical trials, give patients access to the latest breakthroughs in treatment. Researchers have conducted more than 300 clinical trials for mesothelioma worldwide.

Bar graph showing the number of mesothelioma clinical trials per top five countries.
The United States remains a powerhouse for medical research.
Source: ClinicalTrials.gov

Mesothelioma Costs and Compensation

  • Costs: $60,000
    The National Cancer Institute statistics estimate the cost of lung cancer treatment at more than $60,000 for the first year. Mesothelioma treatment costs are comparable.
  • Claims: $180,000
    The RAND Corporation estimated the median value for mesothelioma claims as $180,000 in a 2010 research report. A 2019 analysis from consulting firm KCIC shows 2,087 mesothelioma lawsuits were filed in 2018.
  • Trusts: $30 Billion
    In 2016, the RAND Corporation’s Institute for Civil Justice reported asbestos bankruptcy trusts hold a combined total of more than $30 billion. These trusts have paid claimants roughly $20 billion since the late 1980s.

Learn How a Qualified Mesothelioma Lawyer Can Help

Exposed to Asbestos in the Military?

File a VA Claim
Asbestos.com Mesothelioma Packet

Get Your Free Mesothelioma Guide

Get Yours Now

Need Financial Help for Your Mesothelioma?

Find Out How

Registered Nurse and Patient Advocate

Karen Selby joined Asbestos.com in 2009. She is a registered nurse with a background in oncology and thoracic surgery and was the regional director of a tissue bank before becoming a Patient Advocate at The Mesothelioma Center. Karen has assisted surgeons with thoracic surgeries such as lung resections, lung transplants, pneumonectomies, pleurectomies and wedge resections. She is also a member of the Academy of Oncology Nurse & Patient Navigators.

Walter Pacheco, Managing Editor at Asbestos.com
Edited by
Reviewed by placeholder
Medical Review By

15 Cited Article Sources

  1. American Cancer Society. (2019, March 6). Survival Rates for Mesothelioma.
    Retrieved from: https://www.cancer.org/cancer/malignant-mesothelioma/detection-diagnosis-staging/survival-statistics.html
  2. American Cancer Society. (2019, January 9). Survival Rates for Mesothelioma.
    Retrieved from: https://www.cancer.org/cancer/malignant-mesothelioma/about/key-statistics.html
  3. Cancer.net. (2019, January). Mesothelioma: Statistics.
    Retrieved from: https://www.cancer.net/cancer-types/mesothelioma/statistics
  4. KCIC. (2019). Asbestos Litigation: 2018 Year In Review.
    Retrieved from: https://www.kcic.com/media/1918/kcic-2018-asbestos-report.pdf
  5. Powers, J. (2018, April 17). Analysis Supports Combination Therapy in Patients With Malignant Pleural Mesothelioma: Presented at ELCC.
    Retrieved from: https://www.firstwordpharma.com/node/1557746
  6. Powers, J. (2018, April 13). Endoglin Levels Signal Nintedanib Response in Patients With Malignant Pleural Mesothelioma: Presented at ELCC.
    Retrieved from: https://www.firstwordpharma.com/node/1556853?tsid=17
  7. Mazurek, J. et al. (2017, March 3). Malignant Mesothelioma Mortality — United States, 1999-2015.
    Retrieved from: https://www.cdc.gov/mmwr/volumes/66/wr/mm6608a3.htm#T1_down
  8. Beebe-Dimmer, J. et al. (2016, October 26). Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival.
    Retrieved from: https://www.dovepress.com/mesothelioma-in-the-united-states-a-surveillance-epidemiology-and-end--peer-reviewed-fulltext-article-CLEP
  9. Henley, S. et al. (2015, April 22). Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008.
    Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406225/
  10. Taioli, E. et al. (2014, September). Women with malignant pleural mesothelioma have a threefold better survival rate than men.
    Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/24928677
  11. National Cancer Institute. (2011, January). Annualized Mean Net Costs of Care per Patient.
    Retrieved from: https://costprojections.cancer.gov/annual.costs.html
  12. Dixon, L., McGovern, G. & Coombe, A. (2010). Asbestos Bankruptcy Trusts: An Overview of Trust Structure and Activity with Detailed Reports on the Largest Trusts.
    Retrieved from: http://www.rand.org/content/dam/rand/pubs/technical_reports/2010/RAND_TR872.pdf
  13. Surveillance, Epidemiology, and End Results Program. (n.d.). Age-Adjusted SEER Cancer Incidence Rates, 1980-2015.
    Retrieved from: https://seer.cancer.gov/archive/csr/1975_2015/browse_csr.php?sectionSEL=17&pageSEL=sect_17_table.01
  14. Surveillance, Epidemiology, and End Results Program. (n.d.). Age-Adjusted Rates and Trends by Race/Ethnicity and Sex.
    Retrieved from: https://seer.cancer.gov/archive/csr/1975_2015/browse_csr.php?sectionSEL=17&pageSEL=sect_17_table.11
  15. Surveillance, Epidemiology, and End Results Program. (n.d.). Mesothelioma 5-Year Relative and Period Survival by Race, Sex, Diagnosis Year and Age. Retrieved from: https://seer.cancer.gov/archive/csr/1975_2015/browse_csr.php?sectionSEL=17&pageSEL=sect_17_table.04
  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

On This Page

Back to Top

Share this article

Last Modified September 12, 2019

Chat live with a patient advocate now